ESPN’s T.J. Quinn refuses to vote for the Hall of Fame and has a lot of good reasons for it

67 Comments

ESPN’s T.J. Quinn was a beat writer for many years, covering the White Sox and Mets and then moved on to do investigative reporting for the New York Daily News and ESPN, with a huge emphasis on covering performance enhancing drugs in sports. If there is any Hall of Fame voter, therefore, who is qualified to assess how PEDs and the Hall of Fame mix, it’s him.

Except he has decided that even he can’t do it and gave up voting for the Hall of Fame two years ago. Today he explains why:

Even before the issue of performance-enhancing drugs overwhelmed the annual conversation, I questioned my capacity to evaluate a player’s fitness for immortality. My only qualification, like all voters, was 10 years’ service as a BBWAA member. But nothing in my years as a beat writer covering the Chicago White Sox and New York Mets, and nothing in my years covering doping as an investigative reporter since has prepared me to evaluate the effect PED use should have on a player’s legacy.

He goes on to explain why the “keep the juicin’ bums out” arguments are essentially incoherent as generally applied. He also notes — as we have noted here at HBT lately — that it’s kind of a problem to give votes to guys who haven’t actively covered the game in years. Personally I think Quinn is eminently qualified, but even he himself thinks the fact that he hasn’t covered baseball on a day-to-day basis since 2002 prevents him from being up to the task. So who is?

But at the end of the day, the game, the Hall and journalism would be better served if voting was limited to a select group of veterans, historians and even journalists — if they’re the right journalists. Columnists and national writers who have devoted their careers to the game, not dabblers. That wouldn’t solve the problem of how to evaluate players in the age of modern chemistry, but at least the right group would be making the call.

I think it would be hard to come up with the right group of voters — ex-players are a particular problem as I think they are among the least suited to objectively analyze players’ contributions — but I think Quinn is right that the current electorate — ten-year BBWAA veterans who, quite often, aren’t even baseball writers anymore — is the wrong crop.

A lot of food for thought here. It’s nice to see someone with the franchise chewing on it all, even if he chooses not to vote.

Report: Brewers sign Yovani Gallardo to a major league deal

Getty Images
7 Comments

Free agent right-hander Yovani Gallardo is headed back to the Brewers on a major league deal, The Athletic’s Ken Rosenthal reports. No other terms have been reported yet, as the agreement is still pending a physical.

Gallardo, 31, completed a one-year run with the Mariners before getting his $13 million option declined by the team last month. He provided little value during his time in Seattle, pitching to a 5-10 record in 22 starts and putting up a 5.72 ERA, 4.1 BB/9 and 6.5 SO/9 in 130 2/3 innings as both a starter and reliever.

Still, assuming the veteran righty is on the cusp of a comeback, he may as well try for it with his original club. Gallardo last appeared for the Brewers from 2007 to 2014, racking up a cumulative 20.8 fWAR and peaking during the 2010 season, when he earned his first All-Star nomination and Silver Slugger award. This will be his ninth career season with the club.

Even with Gallardo aboard, the Brewers are expected to continue deepening their pitching stores for 2018. With team ace Jimmy Nelson still recovering from shoulder surgery, the club will enter the season with a projected rotation of Gallardo, Zach Davies, Chase Anderson and Junior Guerra, the latter of whom pitched just 70 1/3 innings in 2017 following a right calf strain and shin contusion. Another big name pitcher could help cement Milwaukee’s rotation and keep them competitive for another year, though they don’t appear to have made any concrete moves in that direction so far.